Fraud Claims Against Lilly Tossed In Cymbalta Labeling Row

Law360, New York (August 28, 2015, 2:13 PM EDT) -- A Virginia federal judge on Friday found that two women suing Eli Lilly and Co. for allegedly misrepresenting the withdrawal risks of its antidepressant drug Cymbalta had failed to present enough jury evidence to support their fraud claims, tossing them from court but keeping alive a negligence allegation.

U.S. District Judge Anthony J. Trenga issued his bench order on Friday morning after plaintiffs Gilda Hagan-Brown and Janine Ali wrapped up four days of evidence presentation to a Virginia federal jury on Thursday, granting a motion for judgment...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Ali v. Eli Lilly and Company


Case Number

1:14-cv-01615

Court

Virginia Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Anthony J Trenga

Date Filed

November 25, 2014


Case Title

Hagan-Brown v. Eli Lilly and Company


Case Number

1:14-cv-01614

Court

Virginia Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Anthony J Trenga

Date Filed

November 25, 2014

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.